Filing Details
- Accession Number:
- 0001127602-11-018357
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-02 16:25:08
- Reporting Period:
- 2011-06-01
- Filing Date:
- 2011-06-02
- Accepted Time:
- 2011-06-02 16:25:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874663 | Alkermes Inc | ALKS | Pharmaceutical Preparations (2834) | 232472830 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236441 | A Robert Breyer | 852 Winter St. Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-06-01 | 3,025 | $7.19 | 70,206 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-06-01 | 3,025 | $18.13 | 67,181 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-06-01 | 3,025 | $18.13 | 64,156 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non Qualified Stock Option (Right to Buy) | Disposition | 2011-06-01 | 3,025 | $0.00 | 3,025 | $7.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,450 | 2003-03-18 | 2012-09-18 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This option became exercisable in full six months from the date of grant.